I am very much looking forward to some Prurisol news real
I am very much looking forward to some Prurisol news real soon. With Karin's comment that she was told Leo is out of country, I am sure it's for a very good business reason. I am excited about the POC trial for several reasons:
1. Excellent short term SP catalyst, as putting a drug into humans for a 2nd clinical trial for the company is great news and a significant achievement in itself
2. Rapid results - this trial is the "anti-DF" trial, in just one short month dosing will be complete and we won't have to wait long for results
3. Prurisol is the "anti-K" in the sense that we know its safe, its not completely novel, so we can hit the ground running and hopefully see some dramatic results very quickly right out of the gates
4. It will be nice to focus on Prurisol more closely as the folks at DF are obviously running a tight ship and limiting how much Leo can share, and when
5. Prurisol brings revenue discussion to the table quickly, I beleive if all goes smoothly and we get results by Oct/Nov, Leo could be at the negotiating table by xmas talking partnerships with big pharma to hit the ground running in broader phase 2/3 trials in the US in 2014
5. Prurisol is the more likely catalyst in the near term that can push SP up much higher, and make uplisting to NYSE a much more serious and timely discussion
6. NYSE uplisting opens the flood gates with institutional investors . If you think 2 million shares traded is "high" volume now, just wait until the big players start to build their position, "high" volume will take on a whole new meaning
Lots of great things in the works, as shareholders I think we will all very much enjoy having a 2nd trial in progress, as I know the pacing and info sharing out of DF has been frustrating for many, as necessary as it is to maintain trial integrity.
I hope all goes well with no snags in terms of the POC trial starting up so the above scenarios can play out quickly. But of course, delays are to be expected in biotech, so I am patient , even though I am anxious at the same time. If that makes any sense. lol
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
EcoVadis Silver Badge: Shorr's Green Path Imagine this: Shorr Packaging strutting around with an EcoVadis Silver Badge pinned to its chest for not one, not two, but three years now. That's right, Shorr Packaging's been elbowing its way to the top tier with their sustainability drive, ranked in the 93rd percentile. For those not keeping score, that's top-notch, considering...
Continue Reading
Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...
Continue Reading
An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...
Continue Reading
Anderson University, against all odds, is shaking up the financial narrative they’ve been stuck in for a while. It’s kind of like finding a $20 bill in an old coat—a nice surprise but it doesn’t happen every day. The university’s recent report on their financial progress is reminding folks that when it comes to fiscal discipline, sometimes you just need fresh...
Continue Reading
Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...
Continue Reading
HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...
Continue Reading
Leadership Shifts Steer Agiloft's EMEA Journey Agiloft's latest shake-ups in leadership signal a determined charge through EMEA's bustling markets. Nick Bowles, a seasoned veteran in enterprise software, steps into the limelight as Senior Vice President, while Jim Leason shifts gears into a customer-focused advisory role. These aren’t just routine hiring...
Continue Reading
A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...
Continue Reading
WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...
Continue Reading
Boosting Midday Energy with BIBIBOP's New Promo Here we go, folks. BIBIBOP Asian Grill is dialing up the culinary energy just when you need it most. From November 16 to 22, during their Good Energy Happy Hour, they’re serving up a deal designed to pump some pep into your afternoon—free OLIPOP prebiotic soda with any regular bowl purchase. Just stroll into any of their...
Continue Reading
Top 5 Most Recently Viewed Articles
Candidacy Search for the Board of Directors at SKEL The Nomination Committee of SKEL fjárfestingafélag hf. is actively seeking nominations or candidates for the Board of Directors. This invitation for participation comes ahead of an important annual gathering. Nomination Committee's Role This committee plays a critical advisory role during the election process by...
Continue Reading
Parry Labs Secures Phase II SBIR Award for Spaceport Solutions Parry Labs, renowned for its expertise in modular open systems, has recently achieved a significant milestone by securing a Direct to Phase II Small Business Innovation Research (SBIR) contract from the U.S. Space Force (USSF). This contract is part of the USSF's initiative aimed at revolutionizing spaceport...
Continue Reading
RBC Capital Highlights Growth Potential for NanoXplore RBC Capital has reaffirmed its optimistic view on NanoXplore (GRA:CN) (OTC: NNXPF), keeping an Outperform rating with a price target set at Cdn$3.25. This positive stance comes after the company's recent financial performance in the latest fiscal quarter, where it not only met but also exceeded market expectations,...
Continue Reading
Growth Projections in Heart Valve Repair and Replacement Devices The heart valve repair and replacement devices market is on the brink of substantial expansion, projected to increase by approximately USD 3.73 billion between 2025 and 2029. This impressive growth reflects a Compound Annual Growth Rate (CAGR) of around 9.1%. Key factors contributing to this upward trend...
Continue Reading
Understanding Tesla's Stock Performance Tesla's stock has experienced a tumultuous year, as investors have watched the electric vehicle manufacturer navigate several challenges. The shares have fluctuated significantly, marked by sectors of decline and some attempts at recovery. Recently, Tesla (NASDAQ: TSLA) closed at $339.03, down 16% from the beginning of the year,...
Continue Reading